The intronic lncRNA Prostate Cancer Antigen 3 (PCA3) is a highly specific biomarker: While only present at low levels in normal or benign hyperplastic prostate, its expression is increased up to 100‐fold in about 95% of prostatic carcinomas (Schalken et al, 2003). This evidence concerns the gene PCA3 and prostate carcinoma.